The mission of the Canadian COVID-19 Genomics Network (CanCOGeN) is to establish a coordinated pan-Canadian, cross-agency network for large-scale SARS-CoV-2 and human host sequencing to track viral origin, spread and evolution, characterize the role of human genetics in COVID-19 disease and to inform time-sensitive critical decision making relevant to health authorities across Canada during the …
Living with cancer longer is possible due to better cancer treatments but these treatments can damage the cardiovascular system. This can happen in up to 15-20% of people receiving treatment for breast and other aggressive cancers. The purpose of this project is to develop a state-of-the-art database system, called the CArdiotoxicity Prevention Research Investigation (CAPRI). …
Cardiotoxicity Prevention Research Initiative (CAPRI) Phase 1 – Registry Read More »
Precision Health is an emerging paradigm that promises to improve the health of Albertans by considering each patient’s unique genomic, environmental and lifestyle characteristics to create personalized prevention and treatment plans. To realize the full potential of precision health, newer methods of integrating high quality clinical information with genomic data and methods to improve sharing …
Solve-RD Alberta: A precision health ecosystem for rare diseases Read More »
Unchecked inflammation underlies complex immune-mediated conditions, including arthritis, resulting in significant morbidity and high costs. This project aims to overcome the barriers to integrate precision health data and accelerate its translation and application into practice in the context of inflammatory arthritis. Precision Health requires standardized data collection and integration including clinical, environmental, biologic, and administrative …
Alberta Precision Health Initiative for Arthritis and Complex Immune Diseases Read More »
Precision health represents a spectrum of transformative approaches from medicine to public health. Precision medicine aims to harness a wave of discoveries in genomics to deliver the right treatment to the right patient at the right time. Precision public health aims to apply those discoveries to better direct public health interventions. The Alberta Laboratory for …
The GAPH Network brings together GE3LS (the Genomics and its ethical, environmental, economic, legal, and social aspects) components of the 17 projects funded through Genome Canada’s Genomics and Personalized Health programme (GAPH), with the objectives of: sharing best practices, improving and priming future collaborative research endeavours, accelerating the progress to market of GAPH technologies, and …
GE3LS network in genomics and personalized health Read More »
CARE for RARE is a collaborative pan-Canadian project configured to improve the diagnosis and treatment of rare diseases. The team will use new powerful DNA sequencing methods to discover 60 new genes, each of which causes a rare disease. The identification of new genes provides useful biological information, giving us insight into cellular pathways significant …
Enhance CARE for RARE genetic diseases in Canada Read More »
Recently it was identified that during pregnancy, there is fetal DNA in maternal blood in sufficient quantities to be analysed and methods have been proposed to detect the presence or not of a fetus with Down syndrome using maternal blood. The introduction of genomic blood testing as proposed in the context of this project could …
PEGASUS: Personalized genomics for prenatal aneuploidy screening using maternal blood Read More »
The SpecTRA project (Spectrometry for TIA Rapid Assessment) is an emergency medicine and neurology project designed to reduce the occurrence of stroke through early detection of early warning signs. Stroke accounts for the greatest use of acute and chronic care beds in Canada, with large economic and social costs associated with treatment and rehabilitation. The …
Reducing stroke burden with hospital-ready biomarker test for rapid TIA triage Read More »
The goal of personalized medicine (PM) is to tailor medical treatments and services to the biological makeup of individual patients. This project provides a way to maximize investments made in PM technology to secure patient benefits, lower health care costs, and waste fewer resources. It does so by bridging informational gaps between PM researchers, developers, …
Follow Genome Alberta on social media to stay informed, expand your network and discover new resources.
© 2023 Genome Alberta. All rights reserved.
Genome Alberta respectfully acknowledges that our head office is located on Treaty 7 territory of the Blackfoot confederacy, Siksika, Kainai and Piikani First Nations, as well as the Stoney Nakoda and Tsuut’ina First Nations. We acknowledge that this territory is home to the Metis Nation of Alberta, Region 3, within the historical Northwest Metis homeland.
We will continue the work of healing and reconciliation in our communities and look forward to building a path to lead us to a better relationship with Indigenous Peoples and the environment around us based on peace, friendship and respect.
https://dev.genomealberta.ca/project/pace-omics-personalized-accessible-cost-effective-applications-of-omics-technologies/
